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Abstract: Under hypoglycemic conditions, concomitant hyperinsulinism causes an apparent
modification of hemoglobin (Hb) which is manifested by its aggregation (Niketi} et al.,
Clin. Chim. Acta 197 (1991) 47). In the present work the causes and mechanisms underlying
this Hb modification were studied. Hemoglobin isolated from normal erythrocytes incu-
bated with insulin was analyzed by applying 31P-spectrometry and lipid extraction and anal-
ysis. To study the dynamics of the plasma membrane during hyperinsulinism, a fluorescent
lipid-analog was applied. In the presence of insulin, phosphatidylserine (PS), phospha-
tidylethanolamine (PE) and cholesterol were found to bind to Hb. Lipid binding resulted in
Hb aggregation, a condition that can be reproduced when phospholipids are incubated with
Hb in vitro. Using a fluorescent lipid-analog, it was also shown that exposing erythrocytes to
supraphysiological concentrations of insulin in vitro resulted in the internalization of lipids.
The results presented in this work may have relevance to cases of diabetes mellitus and
hypoglycemia.
Keywords: insulin, erythrocyte, hypoglycemia, hyperinsulinism, membrane lipids, hemo-
globin.
INTRODUCTION
Human red blood cells (RBC) are known to possess insulin receptors that bind insulin in a
manner similar to that observed for other cell types.1,2 The effects that insulin has upon erythro-
cytes at the molecular and/or structural level are largely unknown. We have demonstrated that
under hypoglycemic conditions, the concomitant hyperinsulinism caused apparent modifica-
tions of hemoglobin (Hb). These modifications are represented by the aggregation of Hb and
by the appearance of a minor Hb fraction, HbA1x (4 % of the total Hb).3,4 The modification of
Hb into HbA1x was shown to be due to covalent binding of glycoinositolphospholipid (GPI)
derived from the RBC membrane to the C termini of both Hb -chains.5
The present work was initiated in order to examine the underlying cause and mecha-
nism of modification of Hb manifested by its aggregation. The molecular properties of he-
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moglobin from normal erythrocytes incubated with insulin were analyzed. The results
demonstrate that supraphysiological concentrations of insulin induces lipid binding to Hb.
Lipid binding causes the Hb to aggregate, a condition that can be simulated when
phospholipids are incubated with Hb in vitro. Furthermore, using a fluorescent lipid-ana-
log,6,7 it was shown that lipid internalization occurs in erythrocytes in response to
supraphysiological concentrations of insulin.
EXPERIMENTAL
Starting materials
Erythrocytes isolated4 from freshly drawn blood samples of normal healthy volunteers were suspended
(1:2) in buffer G, pH 7.41 from which bovine serum albumin was omitted since this protein was found to favor
hemolysis upon prolonged incubation. Incubation with 1 g/ml of porcine insulin (NOVO, Copenhagen,
Denmark) was done at 37 ºC under agitation for 5 h. Controls without insulin were run in parallel. Insulin
binding to the erythrocytes was estimated according to the method of Gambhir.1 Hemolysis of the erythro-
cytes and separation of the Hb fractions by means of gel chromatography on a Sephadex G-100-120 column
(Pharmacia) were as described previously.4 For calibration of the column, glutaraldehyde-linked Hb oligo-
mers of known molecular sizes8 were used. The concentration of Hb was determined by CN-methemoglobin
procedure as described by Tentori and Salveti.9
Incubation of Hb with phospholipids and cholesterol
The hemolysates prepared from normal erythrocytes were extensively dialyzed against distilled water
followed by incubation with either phosphatidylserine (PS) or phosphatidylethanolamine (PE) alone or in
combination with cholesterol (all from Sigma) in the following molar ratios: Hb:phospholipid 5:1; Hb:pho-
spholipid:cholesterol 5:1:0.5. The lipids were dissolved in a 1:1 (v/v) mixture of Triton X-100 and 60 mM so-
dium phosphate (SP) buffer pH 7.4. Twenty l of this solution were added to 1 ml of Hb solution (15 mg/ml)
followed by incubation at 37 ºC for 3 h. The Hb solution (1 ml) containing 20 l of Triton X-100 and SPbuffer
mixture was incubated as a control.
31P-NMR Methods
For 31P-NMR studies, Triton X-100 (to a final concentration of 5 %) was added to the Hb samples
eluted from the Sephadex column. The 31P-NMR spectra of membrane samples (containing 5 % Triton
X-100) isolated from normal RBC10 were used for comparison. The NMR spectral data were obtained on a
Bruker MSL 400 instrument operating in the Fourier transform mode at 161.981 MHz. All experiments were
carried out at 22 ºC under full broad-band decoupling conditions. The number of transitions that were accu-
mulated was 40,000. All chemical shifts are reported relative to external 85 % phosphoric acid.
Lipid extraction and analysis
The Hb fractions eluted from the Sephadex column were lyophilized, dissolved in water (60–130 mg in
0.6 ml of water) and the lipids were extracted according to the procedure of Bligh and Dyer.11 The lipid phos-
phorus levels were determined as described by Bottcher.12 The cholesterol levels were estimated by an enzy-
matic assay using a commercial kit (Human GmbH). Thin layer chromatography (TLC) was performed on
Silica Gel 60 HPTLC plates (Merck) using CHCl3/ CH3OH/ 20 % NH4OH (70:30:5) as the solvent system.
Insertion of fluorescent lipids and lipid internalization
To insert the fluorescent lipid analogue 1-acyl-2-6-(7-nitro-2,1,3-benzoxadiazol-4-yl)aminocapro-
ylphosphatidylcholine (C6-NBD-PC) (Avanti Biochemicals) into the erythrocyte plasma membrane, a pro-
cedure similar to that described by Kok et al.6 was applied. The lipid (15 nmol) (stored in chloroform/metha-
nol (2:1)) was dried under nitrogen and subsequently solubilized in 50 l of absolute ethanol. The ethanolic
lipid solution was rapidly injected into a solution of 1 ml 120 mM KCl/ 30 mM NaCl/ 10 mM Na2HPO4
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(KNP) buffer pH 7.4, under vigorous vortexing. This solution was then added to a tube containing 5109 /ml
erythrocytes in 9 ml KNP buffer. Labeling was carried out for 30 min at 37 ºC with mild shaking.
Non-inserted (free) lipid was removed by washing the erythrocytes. The cells were resuspended in 25 ml of
incubation buffer to a final erythrocyte concentration of 2108 /ml. To initiate the internalization of the mem-
brane-inserted lipid, the cells were incubated with insulin (1 g/ml) as described above. A control without in-
sulin was run in parallel.
Back-exchange of membrane inserted lipid
Back-exchange was carried out by incubating erythrocytes with small unilamellar vesicles of diole-
ylphosphatidylcholine (DOPC SUV). The liposomes were prepared by suspending the dried lipids in KNP
buffer followed by sonication for 15 to 30 min. Twenty microlitre of 8 mM DOPC SUV (500 mnmol/ml) was
added to 1 ml of erythrocyte suspension and incubated with continuous rotation for 15 min at room tempera-
ture. The erythrocytes and liposomes were separated by centrifugation. Subsequently, the cells were subjected
to another round of back-exchange. The fluorescence in the pooled supernatants (back-exchange fraction) and
cells was determined after addition of Triton X-100, 1 % v/v. The fluorescence was measured using a
Perkin-Elmer MPF-43 fluorescence spectrophotometer. For C6-NBD-PC, the excitation and emission wave-
lengths were 465 and 530 nm, respectively.
Microscopy
Fluorescence microscopic examination was performed with a Leitz Orthoplan microscope equipped
with a Leitz Vario Orthomat 2 photographic system and the following filter set: blue excitation, BP 450 to
490/LP515 (NBD channel). The photomicrographs were taken at 30 s exposure times, using a Kodak T-max
P3200 film that was processed at 12800 ASA.
RESULTS
Previous gel filtration studies demonstrated that under hypoglycemic conditions con-
comitant hyperinsulinism caused, both in vivo and in vitro apparent modifications which
were manifested by the aggregation of Hb.4 31P measurements demonstrated that the Hb
aggregates from normal RBC incubated with insulin eluted from a Sephadex column con-
tained phospholipids (PL). No phospholipids were detected in Hb from control samples.
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Fig. 1. 31P-NMR spectra of soluble red cell membranes
and Hb aggregates. (A) soluble red cell membranes to
saturation in 5 % Triton X-100, pH 7.1. (B) Hb aggre-
gates isolated by means of Sephadex column from nor-
mal RBC incubated with insulin (25 mg/ml) in 5 % Tri-
ton X-100, pH 7.0. For experimental details see the Ex-
perimental section.
Figure 1 compares the representative 31P spectra of RBC membranes (pH 7.1) and Hb ag-
gregates (pH 7.0) from normal erythrocytes incubated with insulin. The striking difference
between the two spectra is the lack of the signal resonating at – 0.15 ppm in the spectrum of
Hb aggregates. By comparison with published phospholipid chemical shift data,13,14 the
resonance at 0.2 ppm is assigned to PE and the resonance at – 0.15 ppm is assigned to PC.
However, because of the similarity in 31P chemical shift for these lipids, the 31P resonance
from PS is certainly represented in the 0.2 ppm resonance.
The tight binding of PL to Hb in Hb aggregates is demonstrated by the fact that it is
impossible to remove the PLby gentle ultrafiltration techniques. However, extensive dialy-
sis resulted in the partial removal of the bound PL. The binding of proteins to negatively
charged lipids is predominantly electrostatic in nature, and is reduced by increasing the
ionic strength.15,16 Indeed, elution of the Sephadex column with buffer or salt solutions
such as 0.15 M NaCl resulted in the dissociation of the Hb aggregates. Under these condi-
tions, Hb from insulin-treated cells eluted as a single peak. This elution profile is similar to
that of Hb from untreated cells (data not shown).
The Hb aggregates, recovered by gel filtration as described above, were further ana-
lyzed to determine the nature of the PL present. The lipids were extracted and a qualitative
assessment of the lipid composition was achieved by thin layer chromatography (data not
shown). Only PE and PS were detected in the Hb aggregates derived from erythrocytes
that had been exposed to insulin. A quantitative determination of the phospholipid (phos-
phorus assay) and cholesterol levels from the various samples of Hb aggregates revealed
the association of ca. 0.1 mol of phospholipid and 0.05 mol of cholesterol per mole of Hb
in cells treated with insulin.
The association of lipids with Hb as revealed by the above data may suggest that
lipids play an active role in causing the aggregation of Hb under conditions of hyperinsu-
linism. To obtain more direct experimental support for such a mechanism, Hb isolated
from normal RBC was incubated with either PS or PE alone or in combination with cho-
lesterol, followed by gel chromatography. Under the applied experimental conditions, PS
and PE induced aggregates of a size comparable to that of trimers and a mixture of dimers
and monomers, respectively (Fig. 2). Addition of cholesterol caused an increase in the elu-
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Fig. 2. Elution pattern of hemoglobin
incubated with phosphatidylserine (PS)
or phosphatidylethanolamine (PE) on
Sephadex G-100-120 column. Hemo-
lysates from normal erythrocytes were
prepared and incubated with lipids as
described in Experimental section. Ex-
perimental conditions: 0.5 ml of he-
molysate containing about 40 mg of Hb
was applied on a 1.575 cm column
equilibrated and eluted with distilled
water at a flow rate of 20 ml/h. Frac-
tions of 3 ml were collected.
tion volumes for Hb fractions containing phospholipids (results not shown), indicative of
smaller aggregates.
Internalization of the erythrocyte membrane
Hb could acquire lipids either by direct monomeric transfer of the lipid between the
plasma membrane and the protein, or after internalization of the membrane by invagi-
nation. To gain further insight, a fluorescent lipid analogue, C6-NBD-PC, was employed to
study the dynamics of the plasma membrane during hyperinsulinism. The analogue was
inserted into the outer leaflet of the erythrocyte membrane as described in the Methods. Its
exclusive presence in the outer leaflet was confirmed by demonstrating that the entire
membrane-inserted lipid fraction could be removed by back-exchange with unlabeled lipid
vesicles (cf. Fig. 4c (control)). When C6-NBD-PC labeled cells were subsequently incu-
bated with insulin in G-buffer, internalization of the analogue was observed. Back-ex-
change revealed that approximately 10 % of the plasma membrane fraction had internal-
ized during a 5 h incubation period at 37 ºC (Fig. 3).
Fluorescence microscopy revealed that the internalized fraction of the lipid analogue
was present in distinct spots, presumably representing intracellular vesicular structures.
Usually, three to four of such structures per erythrocyte were detected (Fig. 4). Their ap-
pearance was a gradual process, the first vesicles appearing after three hours of incubation.
After 5 h of incubation, the process appears completed as, reproducibly, no further increase
in the number of vesicles (beyond 3–4) was seen. Note that the kinetics of vesicle appear-
ance is in accordance with the kinetics of lipid internalization, as presented in Fig. 3.
DISCUSSION
In this work evidence is presented that supraphysiological concentrations of insulin
can cause interactions between lipids derived from RBC membranes and Hb. These inter-
actions occurred under conditions of low ionic strength and resulted in the formation of
loosely associated Hb aggregates.
Under conditions of hyperinsulinism, down regulation of the receptor occurs, causing
its internalization.17 Under such conditions it was found that PE, PS and cholesterol (at a
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Fig. 3. Kinetics of internalization of the
fluorescent lipid analog as revealed
from the difference in the fluorescence
of the back-exchange fraction ( %Bx)
from C6-NBC-PC labeled erythrocytes
incubated with insulin and the respec-
tive control. For experimental details
see the Experimental section.
phospholipid to cholesterol ratio of ca. 1:0.5) were bound to Hb, and, most likely, cause the
protein to aggregate. The latter is supported by experiments which demonstrated that exog-
enous addition of these lipids can simulate such an event. Application of the fluorescent
lipid analogue (C6-NBD-PC) allowed the ready detection and visualization of the internal-
ization of labelled lipids integrated into the membrane in the cell. Approximately 10 % of
the total C6-NBD-PC pool became internalized over a period of approx. 5 h This percent-
age is consistent with the fraction of internalized membrane-lipids associated with Hb (in
aggregates). That is, given the amount of Hb in RBC (3 mol/ml packed RBC) and the
amounts of lipid in the RBC membrane (1.6–2.3 mol/ml RBC of phospholipids and
1.7–2.1 mol/ml RBC of cholesterol),18 it was calculated that approximately 15 % of the
membrane lipids were internalized in RBC exposed to insulin. Therefore, this energy de-
pendent internalization of insulin receptors in erythrocytes (shown previously to occur in
response to exposure of erythrocytes to high concentrations of insulin)17 is accompanied
by a concomitant internalization of the membrane lipids.
Given the monomeric exchange properties of the fluorescent lipid analogue and in
light of its restricted localization to defined areas within the cell, a vesicular internalization
mechanism is suggested. The C6-NBD-PC lipid appeared to be restricted to the inner leaf-
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Fig. 4. Localization of the fluorescence lipid analog:
(a) C6-NBC-PC labeled erythrocytes incubated with
insulin for 3 h followed with back-exchange; (b)
phase contrast image of (a); (c) the same as (a) but
without insulin. For experimental details see the Ex-
perimental section.
a) b)
c)
let of the internalized vesicle. In this regard, these findings support previous suggestions
that internalized insulin receptors are present in inside-out vesicles.19 Accordingly, at the
leaflet facing the cytoplasm, PS and PE will be exposed, as these lipids are predominantly
restricted to the inner leaflet of the erythrocyte membrane. Since C6-NBD-PC is not found
associated with Hb in Hb aggregates, PS, PE and cholesterol likely gain access to Hb as
monomers, rather than as whole vesicles acting as nucleation sites for Hb. It was found that
apohemoglobin causes the disruption of PS vesicles and the formation of micellar pro-
tein/lipid complexes.20 It seems reasonable to suggest that upon prolonged exposure, PS
(and also PE), which can no longer engage in dynamic interactions with the cytoskeleton,
may become prone to ’exchange’ with Hb, which itself contains a high-affinity binding site
for PS (see below). Consequently this scenario leads to Hb aggregation and the likely de-
struction of the internalized vesicles.
Using RBC membranes and lyposomes, numerous studies have demonstrated that
Hb binds to negatively charged phospholipids. These interactions are reduced as the pH is
increased, but still exist in the physiological pH range.21 Hemoglobin/phospholipid inter-
actions are characterized initially by very rapid electrostatic, followed by hydrophobic in-
teractions.21–23 The nature of the negatively charged phospholipids is important in pro-
moting the interaction with Hb. For example, the effect of phosphatidic acid is greater than
that of phosphatidylinositol which is congruent to that of phosphatidylglycerol being
greater than that of phosphatidylserine.24 Cholesterol inhibits both the hydrophobic and
ionic interactions between Hb and the phospholipid21,25 which may explain the findings
that the presence of cholesterol resulted in a decrease in the size of the Hb aggregates.
Interaction of hemoglobin with negatively charged phospholipids induces Hb oxida-
tion, the dissociation of the heme-globin complex and the denaturation of Hb.24–26 For Hb
aggregates isolated from insulin-treated RBC, a blue shift in the Soret band from 416 to
414 nm along with the appearance of a small peak at 650 nm characteristic of iron-free
porphyrin were observed. Taken together, these data suggest the dissociation of the
heme-globin complex and subsequent removal of iron from the porphyrin ring.24 Pho-
spholipid-induced Hb oxidation can be associated with lipid peroxidation.27,28 Indeed, the
formation of thiobarbituric acid-reactive substances (TBARS)28 was found to be approxi-
mately 1.5 times greater in insulin-treated RBC than in the respective control.
The results described in the present work may bear relevance to studies of physiologi-
cal disorders that are characterized by hyperinsulinism. Such diseases include cases of dia-
betes mellitus and hypoglycemia.29–31 Insulin-induced lipid binding to Hb may represent
one of the sources of free radicals in insulin-treated diabetic patients who have been gener-
ally described as being under enhanced oxidative stress.30 Aggregation of Hb can be de-
tected 10 days after pancreotomy in hypoglycemic patients after the normal concentrations
of insulin and glucose have been reestablished.4 Hyperinsulinism triggered, apart from Hb
aggregation, the formation of a GPI adduct of Hb.8 The GPI adduct of Hb could be de-
tected even 30 days after pancreotomy.4 The detection and monitoring of chronic hy-
perinsulinism could be improved and/or facilitated by a means to identify the existence
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(and consequently levels) of not only Hb aggregates but also the GPI adduct of Hb. Future
work, employing the current system and approach will contribute to unraveling the under-
lying mechanism by which Hb acquires lipids under hyperinsulinism and hypoglycemia
conditions.
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I Z V O D
VEZIVAWE LIPIDA ZA HEMOGLOBIN POD DEJSTVOM INSULINA
NENAD TOMA[EVI]1, MILAN NIKOLI]1, KAREN KLAPPE2, DICK HOEKSTRA2 i VESNA NIKETI]1
1Hemijski fakultet, Univerzitet u Beogradu, Studentski trg 12–16, p. pr. 158, 11001 Beograd i 2Laboratory of
Physiological Chemistry, University of Groningen, Bloemsingel 10, 9712 KZ Groningen, The Netherlands
U ranijim radovima je pokazano da hiperinsulinizam u uslovima hipoglikemije izaziva
modifikaciju molekula hemoglobina koja se manifestuje wegovim agregirawem (Niketi} et al.,
Clin. Chim. Acta 197 (1991) 47). U ovom radu ispitivana je ova modifikacija molekula hemo-
globina, kao i mehanizam wenog nastajawa. Primenom 31P-spektrometrije i analizom li-
pidnog ekstrakta utvr|eno je da u normalnim eritrocitima inkubiranim sa insulinom
dolazi do vezivawa fosfatidil-serina, fosfatidil-etanolmina i holesterola za molekul
hemoglobina. Vezivawe fosfolipida za hemoglobin dovodi do wegovog agregirawa {to je
potvr|eno eksperimentima u kojima je hemoglobin inkubiran sa fosfolipidima in vitro.
Primenom fluorescentnog lipidnog analoga pokazano je da pri izlagawu eritrocita supra-
fiziolo{kim koncentracijama insulina dolazi do internalizacije membranskih lipida.
Dobijeni rezultati mogu biti od zna~aja za pacijente obolele od {e}erne bolesti i hi-
poglikemije.
(Primqeno 22. jula 2002)
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